Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy

Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants

(2009) Kirsten P. Perrett et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A Randomized Trial to Determine the Tolerability and Immunogenicity of a Quadrivalent Meningococcal Glycoconjugate Vaccine in Healthy Adolescents

(2009) Lisa A. Jackson et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Emergence of Endemic Serogroup W135 Meningococcal Disease Associated with a High Mortality Rate in South Africa

(2008) A. von Gottberg et al.   CLINICAL INFECTIOUS DISEASES

Genetic characteristics of serogroup A meningococci circulating in China, 1956–2005

(2008) X. Zhang et al.   CLINICAL MICROBIOLOGY AND INFECTION

Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants

(2008) Matthew D. Snape et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines

(2008) J. E. Russell et al.   MICROBIOLOGY-SGM

Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases

(2008) Angela Bardotti et al.   VACCINE

Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years

(2008) Lars Østergaard et al.   VACCINE

Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa

(2008) Che-Hung Lee et al.   VACCINE

Meningococcal disease: Risk for international travellers and vaccine strategies

(2007) Annelies Wilder-Smith   Travel Medicine and Infectious Disease